The Lack of Systemic and Subclinical Side Effects of Botulinum Neurotoxin Type-A in Patients Affected by Post-Stroke Spasticity: A Longitudinal Cohort Study

The Lack of Systemic and Subclinical Side Effects of Botulinum Neurotoxin Type-A in Patients Affected by Post-Stroke Spasticity: A Longitudinal Cohort Study

Botulinum Neurotoxin type-A (BoNT-A) is the treatment of choice for focal post-stroke spasticity (PSS). Due to its mechanism of action and the administration method, some authors raised concern about its possible systemic diffusion leading to contralateral muscle weakness and autonomic nervous syste...

Full description

Bibliographic Details
Main Authors: Marco Battaglia, Margherita Beatrice Borg, Lara Torgano, Alberto Loro, Lucia Cosenza, Michele Bertoni, Alessandro Picelli, Andrea Santamato, Marco Invernizzi, Francesca Uberti, Claudio Molinari, Stefano Carda, Alessio Baricich
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Toxins
Subjects:
muscle spasticity
botulinum toxin
heart rate
stroke
autonomic nervous system
rehabilitation
Online Access:https://www.mdpi.com/2072-6651/14/8/564

Internet

https://www.mdpi.com/2072-6651/14/8/564

Similar Items